The role of economic evaluation in the pricing and reimbursement of medicines
References (31)
- et al.
No cure, no pay: an acceptable way of financing fertility treatments?
Health Policy
(1989) Price regulation in the pharmaceutical industry: prescription of placebo?
Journal of Health Economics
(1995)- et al.
Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including economic analysis
(1995)Ontario guidelines for economic analysis of pharmaceutical products
(1994)Guidelines for economic evaluation of pharmaceuticals: Canada
(1994)Program established to evaluate cost-effectiveness of new prescription drugs
News Release
(1995)- et al.
Economic evaluation of pharmaceuticals: a European perspective
PharmacoEconomics
(1993) - et al.
New developments in pricing and drug reimbursement in France
PharmacoEconomics
(1994) Prescription drugs; spending controls in four European Countries
GAO/HEHS-94-30
(1994)
Development of reference prices in Germany
Pharmaceutical pricing and reimbursement in the single European market: consensus or conflict?
Pricing and reimbursement of pharmaceuticals in Sweden
PharmacoEconomics
(1994)
Riksförsäkringsverkets föreskrifter om fastställande av pris pa läkemedel.
Cited by (0)
Copyright © 1997 Published by Elsevier B.V.